Drug intelligence / Profile preview

insulin + glutathione

Development stage
Preclinical
Lead developer
Novo Nordisk
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Intravenous, Intramuscular, Oral (glutathione, In Studies)
01

Overview

**Insulin + glutathione** is a combination of two distinct agents: insulin, a peptide hormone that regulates glucose metabolism, and glutathione, a tripeptide acting primarily as an intracellular antioxidant. This combination has been investigated primarily in preclinical and experimental settings for its effects on oxidative stress, cellular antioxidant capacity, and metabolic modulation—especially relevant in diabetes and states of insulin resistance. Insulin restores hepatic glutathione levels and enhances glutathione synthesis rates in erythrocytes, increasing antioxidant defenses and decreasing lipid peroxidation markers. Glutathione, when co-administered, may further modulate cellular redox status, and, in conjunction with insulin (as well as with nitric oxide donors), increased insulin sensitivity has been observed in experimental models. The direct clinical use and standardized drug formulation of "insulin + glutathione" as a single marketed product does not appear to exist, but the combination is studied experimentally for metabolic and antioxidant effects[1][2][3][4].

Other names
intranasal insulin and glutathioneintranasal INS-GSH
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on insulin + glutathione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on insulin + glutathione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call